Neovasc Inc.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ for the treatment of refractory angina and the Tiara™ technology in development for the transcatheter treatment of mitral valve disease. To receive Neovasc updates via email, please register at: http://www.neovasc.com/register.
Neovasc Inc.
Shockwave Medical focuses on developing and commercializing innovative intravascular lithotripsy (IVL) technology to transform the treatment of calcified cardiovascular disease.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
Shockwave Reducer device
Balloon-expandable device technology
Service Requirements
Training and support for physicians on the use of the device
Implantation by trained healthcare professionals
Infrastructure Requirements
Cardiac catheterization labs equipped for percutaneous interventions
Talent Requirements
Clinical trial management expertise
Regulatory affairs specialists
Sales and marketing professionals experienced in medical devices
Engineers specialized in balloon-expandable device technology
AI Insights
Growth Trajectory
With ongoing clinical trials and regulatory submissions, Shockwave Medical demonstrates significant growth potential in the interventional cardiology and vascular surgery markets.
Market Opportunity
Shockwave Medical has a strong market opportunity to establish IVL as the standard of care for treating calcified cardiovascular disease, particularly in patients who are not suitable candidates for traditional revascularization procedures.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats